Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.
Scuderi S; Targeted Biopsies Prostate Cancer Collaborative Group; Tin AL, Marra G, Bianchi L, Kesch C, Soeterik TFW, Ploussard G, Zattoni F, Ettala O, Røder A, Poyet C, Stroomberg HV, Cimmino U, Fiard G, Nordström T, Patel HD, Gupta GN, Yonover PM, Guillaume B, Gaffney C, Zhuang J, Wang Y, Sarkis J, Jabbour T, Diamand R, Windisch O, Olivier J, Abbadi A, Kim EH, Wang JC, Hu J, Zhu A, Stabile A, Eastham JA, Montorsi F, Briganti A, Gandaglia G; European Association of Urology (EAU) Young Academic Urologists YAU Prostate Cancer Working Party; Vickers AJ.
Scuderi S, et al. Among authors: guillaume b.
J Natl Cancer Inst. 2025 Sep 25:djaf275. doi: 10.1093/jnci/djaf275. Online ahead of print.
J Natl Cancer Inst. 2025.
PMID: 41002165